Cardiovascular trials

AIM HY-INFORM

Ancestry and biological Informative Markers for stratification of Hypertension (The AIM HY Study) is a stratified medicine consortium grant, funded by …

DSSita-02

An inadequate supply of oxygen to the heart, due to narrowed coronary arteries, may result in impaired contractile performance during exercise. The use of glucose rather than fat as the major energy source may enable the heart to continue pumping…

ERICA

COPD is the fourth leading cause of death globally and the only major cause that is predicted to increase in the coming decades. Although COPD is initially a pulmonary disease (traditionally caused by cigarette smoke, but increasingly by biomass…

EVOLUTION

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death globally and the only major cause that is predicted to increase in the coming decades. Although COPD is initially a pulmonary disease (traditionally caused by…

IVORY

Acute coronary syndromes (ACS) result from coronary plaque(s) disruption, which initiates a thrombotic process leading to partial or complete obstruction of the vessel lumen with subsequent myocardial ischaemia and necrosis. The mainstay of…

LILACS

Acute coronary syndromes (ACS) result from coronary plaque(s) disruption, which initiates a thrombotic process leading to partial or complete obstruction of the vessel lumen with subsequent myocardial ischaemia and necrosis. The mainstay of…

OPACE

information coming soon

OPERA-CKD

This is a pilot proposal to understand the changes in physiology in patients undergoing scheduled therapy with Darbepoetin as part of their normal NHS care. It is therefore an observational pilot study of changes in physiology before and after…

POPPY

Information coming soon